{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:34:30Z","timestamp":1778870070908,"version":"3.51.4"},"reference-count":3,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,21]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>To evaluate the sensitivity and specificity of 2-18fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography (<jats:sup>18<\/jats:sup>F-FDG PET\/CT) and ultrasound (US) for staging patients with malignant melanoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>In total, 258 patients (112 men and 146 women; mean age, 61 \u00b1 16years) met the primary inclusion criteria for malignant melanoma without further malignancy proven by histopathology. This was a retrospective study of the diagnostic accuracy. All data were obtained from the hospital\u2019s patient and radiology information system. Patients formed a consecutive series and were examined by 18F-FDG PET\/CT and 176 additionally by US (US as a whole [wUS], peripheral lymph nodes [pUS], abdomen [aUS]), with a total of 584 <jats:sup>18<\/jats:sup>F-FDG PET\/CT and 697 US. <jats:sup>18<\/jats:sup>F-FDG PET\/CT and US revealed 824 and 726 lesions, respectively. Per-patient, per-examination, and per-lesion analyses were also performed. The reference standards used were histopathology or resection of lesions, and follow-up controls using other imaging methods.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Significant differences (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .05) were found in the per-examination for the sensitivity of <jats:sup>18<\/jats:sup>F-FDG PET\/CT (0.80) compared to wUS (0.63) and pUS (0.61), and the specificity of <jats:sup>18<\/jats:sup>F-FDG PET\/CT (0.96) compared to wUS (0.98) and aUS (0.99). In the PLA, there were significant differences in sensitivity and specificity for <jats:sup>18<\/jats:sup>F-FDG PET\/CT (0.83, 0.91) compared to wUS (0.61, 0.98), pUS (0.60, 0.98), and aUS (0.61, 0.99).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>\n                                 <jats:sup>18<\/jats:sup>F-FDG PET\/CT is preferable to US for detecting both lymph node and abdominal metastases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000031092","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T19:01:46Z","timestamp":1666638106000},"page":"e31092","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of 18F-FDG PET\/CT and ultrasound in staging of patients with malignant melanoma"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1033-8411","authenticated-orcid":false,"given":"Philipp","family":"Weber","sequence":"first","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, University Hospital of Basel, Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Arnold","sequence":"additional","affiliation":[{"name":"Group Practice \u201cDermatology on the Rhine\u201d, Basel, Switzerland"},{"name":"Faculty of Medicine, University of Basel, Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Hohmann","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Basel, Basel, Switzerland"},{"name":"Institute of Radiology and Nuclear Medicine, Cantonal Hospital of Winterthur, Winterthur, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: evidence-based changes in the American joint committee on cancer eighth edition cancer staging manual.","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jnci\/djq455","article-title":"Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis.","volume":"103","author":"Xing","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"pkaa097","DOI":"10.1093\/jncics\/pkaa097","article-title":"Subtyping cutaneous melanoma matters.","volume":"4","author":"El Sharouni","year":"2020","journal-title":"JNCI Cancer Spectrum"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:21:11Z","timestamp":1746332471000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":3,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000031092","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,21]]}}}